Thomas mavromoustakos



Yüklə 419 Kb.
səhifə5/5
tarix19.07.2018
ölçüsü419 Kb.
#56647
1   2   3   4   5



103.T. Mavromoustakos, P. Zoumpoulakis, M. Zervou, I. Kyrikou, A. Kapou, N. Benetis.The Use of Computational Analysis to Design Novel Drugs. Proceedings of the ICCMSE 2003 by World Scientific, editor: T.E. Simos.

 

104.Mavromoustakos, T., Zoumpoulakis P., Roumelioti, P., Giatas, N., Vlahakos, D., Iliodromytis, E., Matsoukas, J. Design, conformation and bioactivity of novel angiotensin II receptor antagonists. Biopolymers 71(3), 266 (2003).



 

105.Macpherson A, Neti S, Mannisi J, Mavromoustakos T, Macpherson P


Quantitative predictions from echocardiograms JOURNAL OF HYPERTENSION

21: S326-S327 Suppl. 4 JUN 2003.


106.E. Siapi, T. Mavromoustakos, D. Kovala-Demertzi, C. Vidjeluc, M.A. Demertzis. The thermal effects of platinum (II) and palladium (II) complexes with 2-acetyl pyridine and pyridine-2-carbaldehyde N(4)-ethyl-thiosemicarbazones in membrane bilayers. Inorganic Reaction Mechanisms, 8-10 2004, Athens, Greece.
107.T. Mavromoustakos, K. Ioanna, D. Ioanna, M. Hamzah, D. Costas, S. Xatziantoniou, S. Giatrellis, G. Nounesis. The Modulation of Thermal Properties of Vinblastine by Cholesterol in Membrane Bilayers. Medicinal Chemistry:Drug Design and Development, March 11-13, 2004, Patras, Greece.

 

108.A. Kapou, S. Nikolaropoulos, T. Mavromoustakos. DSC-Evaluated Thermal Effects of Steroidal Carriers of Alkylating Agents on Membrane Bilayers. Medicinal Chemistry:Drug Design and Development, March 11-13, 2004, Patras, Greece.



 

109.I. Kyrikou, C. Poulos, N. Benetis, T. Mavromoustakos. A 31P NMR study of interactions of β-Ala-Tyr and Aminoacid Glu with Phospholipid Bilayers. Medicinal Chemistry:Drug Design and Development, March 11-13, 2004, Patras, Greece.

 

110.E. Mantzourani, T. Tselios, J. Matsoukas, T. Mavromoustakos. Structural Elucidation and Conformational Properties of [Arg91,Ala96] an Antagonist Suppressing the Induction of Experimental Autoimmune Encephalomyelitis (EAE). Medicinal Chemistry:Drug Design and Development, March 11-13, 2004, Patras, Greece.



 

111.V. Saroglou, S. Hatziantoniou, M. Smyrniotakis, T. Mavromoustakos, A. Zompra, V. Magafa, P. Cordopatis, C. Demetzos. Design of New Liposome Formulation and Encapsulation of the Synthetic Anticancer Drug Leuprolide Acetate and Study of its Thermal Effects on Membrane Bilayers. J. Peptide Sci. 2004 (10 Sup)H41. 4th Hellenic Forum on Bioactive Peptides. April 22-24 2004, Patras-Hellas.

 

112.M. Smyrniotakis, I. Kyrikou, K. Demetzos, K. Viras, T. Mavromoustakos. Efforts to Esterify Captopril with Polyethylenoglycol. J. Peptide Sci. 2004 (10 Sup)H52. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.



 

113.N. P. Benetis, I. Kyrikou, T. Mavromoustakos. Spectral Simulations of Static 31P CP NMR Multilamella Bilayer Spectra in the Absence and Presence of Bioactive Dipeptide β-Ala-Tyr or Glu. J. Peptide Sci. 2004 (10 Sup)H53. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.

 

114.A. Zoga, I. Kyrikou, S. Gega, E. Chalkefs, P.M. Minakakis, T. Mavromoustakos. Biophysical Studies on a Novel Antihypertensive AT1 Antagonism MM1. J. Peptide Sci. 2004 (10 Sup)H54. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.



 

115.A. Kapou, M. Zervou, S.G. Grdadolnik, T. Mavromoustakos. 3D-QSAR Antihypertensive Models Based on 2D-NMR and Computational Analysis Driven Low Energy Conformers of Losartan. J. Peptide Sci. 2004 (10 Sup)H54. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.

 

116.K. Potamitis, M. Zervou, I. Kyrikou, E. Siapi, P. Zoumpoulakis, C. Fotakis, D. Christodouleas, K.Viras, A. Kolocouris, S.G. Grdadolnik, T. Mavromoustakos. Conformational Analysis Using 2D NMR Spectroscopy Coupled with Computational Analysis of Valsartan and its Drug:Membrane Interactions. J. Peptide Sci. 2004 (10 Sup)H55. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.



 

117.G. Mousselimi, I. Kyrikou, E. Siapi, C. Fotakis, D. Christodouleas, K. Viras, T. Mavromoustakos. Comparative Thermal and Dynamic Effects of Captopril and Enalapril in Lipid Bilayers Using DSC, Solid State NMR and Raman Spectroscopy. J. Peptide Sci. 2004 (10 Sup) H55. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.

 

118.E. Mantzourani, T. Tselios, J. Matsoukas, T. Mavromoustakos. Structural Elucidation and Conformational Analysis of a Potent Altered Peptide Ligand, [Arg91, Ala96]MBP87-99 Employing Experimental ROE Constraints Combined with Theoretical Calculations and Molecular Modelling. J. Peptide Sci. 2004 (10 Sup)H56. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.



 

119.I. Kyrikou, C. Poulos, N.Benetis, K. Viras, T. Mavromoustakos. Conformational Properties and Interactions of the Toxin Paralysin β-Ala-Tyr and Glu with Phospholipid Bilayers. J. Peptide Sci. 2004 (10 Sup) H58. 4th Hellenic Forum on Bioactive Peptides. April 22-24, 2004 Patras-Hellas.


120.A. Kapou, N. Avlonitis, A. Detsi, M. Koufaki, T. Calogeropoulou, N.P. Benetis, T. Mavromoustakos. CoMFA and CoMSIA 3D-Quantitative Structure-Activity Relationships of New Flexible Antileishmanial Ether Phospholipids. Vol. 1. 253,-256, International Conference of Computational Methods in Sciences and Engineering 2004. (ICCMSE 2004) Editors: T. Simos, G. Maroulis.
121.T. Mavromoustakos, P. Zoumpoulakis, A. Politi, P. Minakaki, G. Kokotos. The Contribution of Docking in the Rational Drug-Design. 6th Conference Medicinal Chemistry:Drug Discovery and Design. March 10-12, 2005, Patras-Hellas.
122.P. Moutevelis-Minakakis, K. Georgikopoulou, C.G. Kokotos, P. Kontogiannis, T. Mavromoustakos. Design and synthesis of novel (S)-pyroglutamic based antihypertensive agents. J. Peptide Science vol. 10, 2004, 3rd International and 28th European Peptide Symposium.September 5-10, 2004. Prague, Czech Republic.
123.P. Moutevelis-Minakakis, C.G. Kokotos, P. Kontogianni, T. Mavromoustakos. Design and synthesis of novel (S)-pyroglutamic acid based antihypertensive agents. Acids and Proteins. Rome, Italy. September 5-9, 2003 and Aminoacids 25(2), 2003.
124.P. Moutevelis-Minakakis, K. Georgikopoulou, V. Magrioti, T. Mavromoustakos, G. Kokotos. Synthesis of new 2-pyrrolidinone antihypertensives starting from natural amino acids. 9th International Congress on Amino Acids and Proteins. Vienna 8-12 August 2005.
125.N.P. Benetis, A. Gili, C. Fotakis, D. Christodouleas, K. Viras, I. Kyrikou, M. Zervou, T. Mavromoustakos. Quantitative Simulation of Static P-1 NMR Spectra under Cross Polarization condition as an aid in the Rational Design of Novel Antihypertensive Drugs. Designing Molecules Against Diseases of Modern Societies. Telloglio Institute of Arts, 159A, Aghiou Dimitriou Str., Thessaloniki, 20-21 May 2005. p. 87-90.
126.T. Mavromoustakos, N. Benetis, M. Zervou, P. Zoumpoulakis, I. Kyrikou, A. Politi, G. Kokotos, M. Minakaki. Design, Synthesis and Biological Evaluation of Novel AT1 Antagonists. Interactions with Membrane Bilayers and AT1 receptor. Designing Molecules Against Diseases of Modern Societies. Telloglio Institute of Arts, 159A, Aghiou Dimitriou Str., Thessaloniki, 20-21 May 2005. p. 128-130.
127.Panagiota Moutevelis-Minakakis, Christoforos G. Kokotos, Panagiota Kontogianni, Kalliopi Georgikopoulou and Thomas Mavromoustakos. (S)-Pyroglutamic acid based design and synthesis of new antihypertensive agents. Peptides 2004. Proceedings of the Third International and Twenty-Eight European Peptide Symposium. September 5-10, 2004-Prague, Czech Republic pages 244-245.
128.Efthimia Mantzourani, Thoedore Tselios, John Matsoukas and Thomas Mavromoustakos. Exploring conformational space and enlightening the structure of a potent altered peptide ligand, [Arg91, Ala96] MBP87-99, applying a combination of 2D NMR and molecular modeling. Peptides 2004. Proceedings of the Third International and Twenty-Eight European Peptide Symposium. September 5-10, 2004-Prague, Czech Republic pages 1041-1042,

129.E.D. Mantzourani, T.V. Tselios, S. Golic-Grdadolnik, J.M. Matsoukas, A. Brancale, J.A. Platts, T.M. Mavromoustakos. Exploration of conformational space of linear EAE antagonist [Arg91, Ala96] MBP87-99 and proposal of a putative bioactive conformation in DMSO-d6. ICCMSE 2005, Vol. 4A pages 398-401 Advances in Computational Methods in Sciences and Engineering 2005. Editors T. Simos and G. Maroulis, Loutraki 22-26 October 2005.


130.T. Mavromoustakos, P. Zoumpoulakis, M. Zervou, N. Benetis. Theoretical Calculations constitute a Valuable Tool to Understand the Molecular Basis of Hypertension. Vol. 4A pages 401-405 Advances in Computational Methods in Sciences and Engineering 2005. Editors T. Simos and G. Maroulis, Loutraki 22-26 October 2005.
131.V. Saroglou, S. Hatziantoniou, M. Smyrniotakis, T. Mavromoustakos, A. Zompra, V. Magafa, P. Cordopatis, C. Demetzos. Design of a New Liposomal Formulation and Encapsulation of the Synthetic Anticancer Drug Leuprolide Acetate. Study of its Thermal Effects on Membrane Bilayers. 4th Hellenic Forum on Bioactive Peptides, 225-233 (2005).
132.N. Benetis, I. Kyrikou, T. Mavromoustakos. Static 31P CP NMR spectral simulations of DPPC bilayers in the absence and presence of bioactive dipeptide β-Ala-Tyr or Glu. 4th Hellenic Forum on Bioactive Peptides, 301-304 (2005).
133.A. Zoga, I. Kyrikou, E. Siapi, S. Gega, E. Chalkefs, P.M-Minakakis, D. Vlahakos, E. Iliodromytis, T. Mavromoustakos. Biophysical Studies on MM1; a Novel Antihypertensive AT1 Antagonist. 4th Hellenic Forum on Bioactive Peptides, 305-308 (2005).
137.A. Kapou, M. Zervou, S.G. Grdadolnik, T. Mavromoustakos. 3D-QSAR Antihypertensive models based on 2D-NMR and Computational Analysis Driven low energy conformers of losartan. 4th Hellenic Forum on Bioactive Peptides, 309-312 (2005).
134.G. Mousselimi, I. Kyrikou, E. Siapi, C. Fotakis, S. Gega, D. Christodouleas, K. Viras, T. Mavromoustakos. Comparative thermal and dynamic effects of captopril and enalapril in lipid bilayers using DSC, solid state NMR and Raman Spectroscopy. 4th Hellenic Forum on Bioactive Peptides, 317-320 (2005).
135.E. Mantzourani, T. Tselios, S.G. Grdadolnik, J. Matsoukas, T. Mavromoustakos. Structural Elucidation and Conformational Analysis of a Potent Altered Peptide Ligand [Arg91, Ala96]MBP87-99, Employing Experimental NOEs Constraints Combined with Theoretical Calculations and Molecular Modeling. 4th Hellenic Forum on Bioactive Peptides, 321-325 (2005).

136.I. Kyrikou, C. Poulos, N. Benetis, K. Viras, T. Mavromoustakos. Conformational Properties and Interaction of the Toxin Paralysin β-Ala-Tyr and Glu with Phospholipid Bilayers. 4th Hellenic Forum on Bioactive Peptides, 337-340 (2005).


137.T. Mavromoustakos, M. Zervou, P. Zoumpoulakis. NMR Spectroscopy: A valuable tool in the weaponry of Medicinal Chemistry. 7th Conference “Medicinal Chemistry:Drug Discovery and Design”, March 8-11, 2006, Patras, Greece.
138.E.D. Mantzourani, T.M.Mavromoustakos, S. Golic-Grdadolnik, J.A. Platts, G.N. Deraos, J.M. Matsoukas, T.V. Tselios. A putative bioactive conformation for the APL of Myelin Basic Protein and inhibitor of Experimental Autoimmune Encephalomyelitis, [Ala96]MBP87-99. 7th Conference “Medicinal Chemistry:Drug Discovery and Design”, March 8-11, 2006, Patras, Greece.
139.C. Potamitis, H. Reis, M. Zervou, M. Papadopoulos, T. Mavromoustakos. Conformational Análisis of AT1 antagonist Valsartan using 2D NMR spectroscopy and Computational Analysis, Determination of thermodynamic parameters through dynamic NMR spectroscopy and semi-empirical calculations. 7th Conference “Medicinal Chemistry:Drug Discovery and Design”, March 8-11, 2006, Patras, Greece.
140.P.M. Minakakis, E. Papavassilopoulou, T. Mavromoustakos, P. Zoumpoulakis, G. Kokotos. Design and Synthesis of a new 2-pyrrolidone antihypertensinve starting from natural amino acid. 5o Hellenic Forum on Bioactive Peptides. 14-16 May 2006, Conference and Cultural Center of the University of Patras.
141.C. Potamitis, H. Reis, M. Zervou, M. Papadopoulos, T. Mavromoustakos. Conformational Analysis of AT1 antagonist valsartan using 2D NMR spectroscopy and computational analysis. Determination of thermodynamic parameters through dynamic NMR spectroscopy and semi-empirical calculations. 5o Hellenic Forum on Bioactive Peptides, 14-16 May 2006, Conference and Cultural Center of the University of Patras.
142.E. Chalkefs, K. Viras, P. Moutevelis-Minakakis, C. Kokotos, T. Mavromoustakos. Conformational Studies of MMK2 and its interaction with model membrane bilayers. 5o Hellenic Forum on Bioactive Peptides, 14-16 May 2006, Conference and Cultural Center of the University of Patras.
143.A. Politis, P. Zoumpoulakis, M. Zervou, K. Georgikopoulou, G. Kokotos, P. Moutevelis-Minakakis, T. Mavromoustakos. Rational design of the potential molecule (5S)-1-(3-hydoxybenzyl)-5-(1H-imidazol-1-ylmethyl)-2-pyrrolidinone (MMK8) for the treatment of hypertension. 5o Hellenic Forum on Bioactive Peptides, 14-16 May 2006, Conference and Cultural Center of the University of Patras.
144.E.D. Mantzourani, T.M. Mavromoustakos, S.G.Gardadolnik, J.A. Platts, G.N. Deraos, J.M. Matsoukas, T.V. Tselios. Towards the proposal of a structural motif for the bioactive APL of myelin basic protein and inhibitor of experimental autoimmune encephalomyelitis, [Ala96]MBP87-99. 5o Hellenic Forum on Bioactive Peptides, 14-16 May 2006, Conference and Cultural Center of the University of Patras.
145.A. Kapou, N.P. Benetis, N. Avlonitis, T. Calogeropoulou, M. Koufaki, T. Mavromoustakos. CoMFA and CoMSIA 3D-QSAR studies of new synthetic antileishmanal ring-substituted ether phospholipids. 3rd Cost B22 Annual Congress, Oral Communications. 1-4 October 2006.
146.S. Durdagi, C. Koukoulitsa, T. Kourouli, T. Andreou, S. Nikas, V. Nahmias, D. Papahadjis, M.G. Papadopoulos, T. Mavromoustakos. Theoretical Investigation of Pharmacokinetic Profile of Synthetic Cannabinoids. The XVI European Symposium on Quantitative Structure-Activity Relationships and Molecular Modelling. 10-17 September 2006 Mediterranean Sea/Italy.

147.E. Mantzourani, T. Tselios, S. Golič Grdadolnik, A. Brancale, J. Matsoukas, J. Platts, T. Mavromoustakos. Conformational Analysis and Molecular Dynamics at the Receptor Level of the Immunodominant Myelin Basic Protein Epitope 87-99 Implicated in Multiple Sclerosis, and its Antagonists Linear Altered Peptide Ligands MGMS Young Modellers' Forum in Conjunction with the RSC MMG, School of Oriental & African Studies (SOAS), London, UK, September 1, 2006. abstracts p.40.


148.P. Moutevelis-Minakakis, T. Mavromoustakos, P. Zoumpoulakis, A. Politi, G. Kokotos. Synthesis of 2-pyrrolidinones as potential antihypertensive drugs. 2nd Hellenic Symposium on Organic Synthesis. From Chemistry to Biology, Medicine and Materials Science. 19-21 April 2007. p44 page 110
149.A. Politi, E. Papavasilipoulou, P. Moutevelis-Minakaksi, G. Kokotos, T. Mavromoustakos. Design and Computational Study of Novel Renin Inhibitors. Hellenic Symposium on Organic Synthesis. From Chemistry to Biology, Medicine and Materials Science. 19-21 April 2007 p55 page 121.
150.S. Durdagi, P.G. Zoumpoulakis, M.G. Papadopoulos, C. Koukoulitsa, D.P. Papahatjis, T. Mavromoustakos. An algorithm for the conformational analysis of flexible drug molecules: A critical aspect for the 3D-QSAR studies and rational drug design. Hellenic Symposium on Organic Synthesis. From Chemistry to Biology, Medicine and Materials Science. 19-21 April 2007 p56 page 122.
151.V. Mouchlis, T. Mavromoustakos, G. Kokotos. Computational Study of binding interactions between human nonpancreatic phospholipase A2 (IIA) and inhibitor FPL 67047XX and analogues. Hellenic Symposium on Organic Synthesis. From Chemistry to Biology, Medicine and Materials Science. 19-21 April 2007 p57 page 123.

152.T. Mavromoustakos (speech). Swedish-Hellenic Life Science Research Conference. 24-26 May 2007, Orebro Sweden. Presentation of Laboratory of Molecular Analysis and talk about the Relationship between bioactivity and Conformation.


153.C. Potamitis, M. Zervou, S. Golic Grdadolnik, I. Kyrikou, V. Katsiara, P. Zoumpoulakis, D. Argyropoulos, G. Vatougia, S. Nikaloropoulos, T. Mavromoustakos. Antihypertensive Drug Valsartan: Conformational Analysis and Determination of the Amide Rotational Barrier using dynamic NMR spectroscopy, comparative superimposition and docking studies with the prototype AT1 antagonist losartan. 8th Conference “Medicinal Chemistry:Drug Discovery and Design”, March 15-17, 2007, PatrasGreece. (Abstract cited in the Review of Clinical Pharmacology and Pharmacokinetics page 28).
154.S. Durdagi, C. Koukoulitsa, A. Kapou, T. Kourouli, T. Andreou, S.P. Nikas, V.R. Nahmias, D.P. Papahatjis, M.G. Papadopoulos, T. Mavromoustakos. The application of 3D-QSAR and pharmacokinetic studies for the novel cannabinoid ligands substituted at the C1΄ position of the alkyl side chain. Medicinal Chemistry:Drug Discovery and Design”, March15-17,2007, PatrasGreece. (Abstract cited in the Review of Clinical Pharmacology and Pharmacokinetics page 29).

155.V. Katsiaras, C. Potamitis, P, Zoumpoulakis, S. Nikolaropoulos, T. Mavromoustakos. Docking Studies of the Antihypertensive Drug Valsartan at the Active Site of the AT1 Receptor. Medicinal Chemistry:Drug Discovery and Design”, March15-17, 2007, PatrasGreece. (Abstract cited in the Review of Clinical Pharmacology and Pharmacokinetics page 54).


156.C. Koukoulitsa, P. Zoumpoulakis, A. Resvani, J. Matsoukas, T. Mavromoustakos. In silico studies of ADME properties of AT1 receptor Antagonists. Medicinal Chemistry:Drug Discovery and Design”, March 15-17, 2007, Patras Greece. (Abstract cited in the Review of Clinical Pharmacology and Pharmacokinetics page 59).

157.T. Mavromoustakos, M. Zervou, P. Zoumpoulakis, C. Potamitis, V. Katsiaras, A. Politi, E. Mantzourani, S. Durdargi, C. Koukoulitsa. Putative Bioactive Conformers of Small Molecules: A Concerted Approach Using NMR Spectroscopy and Computational Chemistry. Drugs Fut 2007, 32,33 (Suppl. A) 6th AFMC International Medicinal Chemistry Symposium.


158.S. Durdagi, C. Koukoulitsa, A. Kapou, T. Kourouli, T. Andreou, S.P. Nikas, V.R. Nahmias, D.P. Papahatjis, M.G. Papadopoulos, T. Mavromoustakos. Drugs Fut 2007, 32 (Suppl. A), 79 6th AFMC International Medicinal Chemistry Symposium.
159.P. Zoumpoulakis, T. Mavromoustakos, M. Rappolt, P. Laggner, G. Rabst. The Role of Membrane Hydrocarbon Chain Composition in Interactions with Antihypertensive Drugs. 51th Annual Biophysical Meeting, March 3-7 Baltimore, Maryland, 2007.
160.T. Tselios, E. Mantzourani, I. Friligou, J. Platts, T. Mavromoustakos, J. Matsoukas. Rational Design of Potent Myelin Basic Protein (MBP) Cyclic Analogues: Exploring the Molecular Basis of Experimental Autoimmune Encephalomyelitis (EAE) Inhibition. 5o Hellenic Forum on Bioactive Peptides, 14-16 May 2006, Conference and Cultural Center of the University of Patras, 209-215 (2007).
161.C. Potamitis, H. Reis, M. Zervou, M. Papadopoulos, T. Mavromoustakos. Conformational Analysis of AT1 Antagonist Valsartan Using 2D NMR Spectroscopy and Computational Analysis. Determination of Thermodynamic Parameters through Dynamic NMR Spectroscopy and Semi-empirical Calculations. 5o Hellenic Forum on Bioactive Peptides, 14-16 May 2006, Conference and Cultural Center of the University of Patras, 267-272 (2007).
162.E. D. Mantzourani, T.M. Mavromoustakos, S.G. Grdadolnik, J.A. Platts, G.N. Deraos, J.M. Matsoukas, T.V. Tselios. Towards the Proposal of a Structural Motif for the Bioactive APL of Myelin Basic Protein and Inhibitor of Experimental Autoimmune Encephalomyelitis, [Arg91, Ala96]MBP87-99. 5o Hellenic Forum on Bioactive Peptides, 14-16 May 2006, Conference and Cultural Center of the University of Patras, 273-276 (2007).
163.(invited speaker) T. Mavromoustakos. Invited by Prof. P. Laggner from Instittue of Biophysical Research (IBR) of Graz Austria to give a lecture. The lecture was given in 14.1.2008 and was entitled “The Molecular Basis of Interdigitation”.
164.S. Durdagi, P.G. Zoumpoulakis, H. Reis, M.G. Papadopoulos, C. Koukoulitsa, D.P. Papahatjis, T. Mavromoustakos. Molecular Docking and Molecular Dynamics Simulations of the potent Δ8-THC analogue AMG3. 13th Hellenic Symposium of Medicinal Chemistry. 14-15 March, Athens, 2008, Greece.
165.A. Politi, S. Durdagi, E. Papavasilopoulou, P. Moutevelis-Minakakis, G. Kokotos, T. Mavromoustakos. 3D QSAR CoMFA/CoMSIA studies on renin inhibitors. 3th Hellenic Symposium of Medicinal Chemistry. 14-15 March, Athens, 2008, Greece.
166.C. Potamitis, M. Zervou, J.M. Hayes, P. Zoumpoulakis, D. Argyropoulos, S. Golic Grdadolnik, T. Mavromoustakos. Antihypertensive drug valsartan: Conformational analysis, thermodynamic properties and docking studies using NMR spectroscopy and in silico methods. 3th Hellenic Symposium of Medicinal Chemistry. 14-15 March, Athens, 2008, Greece.
167.S. Durdagi, H. Reis, M. Papadopoulos, C. Koukoulitsa, T. Mavromoustakos Synergetic Use of 3D QSAR, Molecular Docking and Molecular Dynamics Simulations for the Conformational Analyses of Drugs. 9th International Conference Medicinal Chemistry. Drug Discovery and Design. March 26-28, 2008, Patras, Greece.
168.A. Politi, M. Zervou, P. Zoumpoulakis, A. Zoga, P. Moutevelis-Minakakis, G. Kokotos, T. Mavromoustakos, E.K. Iliodromitis, D.Th.Kremastinos. Hypertension Study in Anaesthesized Rabbits: A New Protocol for AT1 Antagonists Screening. 9th International Conference Medicinal Chemistry. Drug Discovery and Design. March 26-28, 2008, Patras, Greece.
169.C. Potamitis, M. Zervou, T. Tselios, J. Matsoukas, T. Mavromoustakos. Interactions of a pair of synthetic peptide analogues of myelin basic protein with lipid bilayers using DSC and High Resolution Solid State 13C NMR. Screening. 9th International Conference Medicinal Chemistry. Drug Discovery and Design. March 26-28, 2008, Patras, Greece.
170.(invited speaker) T. Mavromoustakos. Membrane Interdigitation and Its Role in Drug Function. The Cyprus Conference CNC on New Methods in Drug Research May 11-16, 2008, Limassol, Cyprus (page 17).
171.S. Durdagi, M. G. Papadopoulos, D. P. Papahatjis, T. Mavromoustakos. Molecular Docking and Molecular Dynamics Simulations on the Improvement of 3D QSAR Results of Novel Δ8-THC Analogues. The Cyprus Conference CNC on New Methods in Drug Research May 11-16, 2008, Limassol, Cyprus (page 26).
172.C. Petrou, S. Mavromoustakos, E. Kokkalou, V. Roussis, E. Christofi, G. Efthimiou, C. Potamitis, S. Durdagi, T. Mavromoustakos. Isolation of psoralens from the Ficus sycomorus juice. A novel approach against psoriasis. The Cyprus Conference CNC on New Methods in Drug Research May 11-16, 2008, Limassol, Cyprus (page 28).
173.V. Mouchlis, T. Mavromoustakos, G. Kokotos. Application of Docking to study the binding affinity between human nonpancreatic phospholipase A2 (IIA) and bioactive analogues of its inhibitor FPL67047XX. The Cyprus Conference CNC on New Methods in Drug Research May 11-16, 2008, Limassol, Cyprus (page 29).
174.A. Politi, S. Durdagi, E. Papavasilopoulou, P. Moutevelis-Minakakis, G. Kokotos, T. Mavromoustakos.3D QSAR CoMFA/CoMSIA studies on renin inhibitors. The Cyprus Conference CNC on New Methods in Drug Research May 11-16, 2008, Limassol, Cyprus (page 30).
175.A. Politi, M. Zervou, P. Zoumpoulakis, A. Zoga, P. Moutevelis-Minakakis, G. Kokotos, E.K. Iliodromitis, D.Th. Kremastinos, T. Mavromoustakos. Hypertension study in anaesthetized rabbitis: A new protocol for AT1 antagonists screening. The Cyprus Conference CNC on New Methods in Drug Research May 11-16, 2008, Limassol, Cyprus (page 31).
176.C. Potamitis, C. Photakis, S. Gega, E. Siapi, K. Viras, P. Moutevelis-Minakakis, C.G. Kokotos, M. Rappolt, T. Mavromoustakos. Comparison study ofteh membrane perturbing ability between AT1 antagonist valsartan and a novel synthetic pyrrolidinone analog MMK3 as depicted by a combination of Differential Scanning Calorimetry and Raman Spectroscopy. The Cyprus Conference CNC on New Methods in Drug Research May 11-16, 2008, Limassol, Cyprus (page 32).
177.T. Mavromoustakos, P.M.Minakakis, G. Kokotos, E. Papavassilopoulou, C. Potamitis, C. Photakis, K. Viras, C. Koukoulitsa, E. Kalatzis, S. Durdagi. Peptide Mimetics and Their Interdigitation with Lipid Bilayers. Page 31. 6o Hellenic Forum on Bioactive Peptides, 18-20 May 2008, Conference and Cultural Center of the University page 31.
178.E. Papavassilopoulou, J. Vranas, P.M. Minakakis, G. Michas, M. Papakonstantinou, A. Politi, T. Mavromoustakos, G. Kokotos. Synthesis of new 2-pyrrolidinones. 6o Hellenic Forum on Bioactive Peptides, 18-20 May 2008, Conference and Cultural Center of the University page 46.
179.E. Papavassilopoulou, P. M. Minakakis, T. Mavromoustakos, A. Politi, G. Kokotos. Design and Synthesis of a Novel Potential Renin Inhibitor. 6o Hellenic Forum on Bioactive Peptides, 18-20 May 2008, Conference and Cultural Center of the University page 50.
180.C. Potamitis, C. Photakis, S. Gega, E. Siapi, K. Viras, P.M. Minakakis, C.G. Kokotos, M. Rappolt, T. Mavromoustakos. Comparison study of the membrane perturbing ability between AT1 antagonist Valsartan and a novel synthetic pyrrolidinone analog MMK3 as depicted by a combination of Differential Scanning Calorimetry and Raman Spectroscopy. 6o Hellenic Forum on Bioactive Peptides, 18-20 May 2008, Conference and Cultural Center of the University page 59.
181.T. Mavromoustakos. 2 one hour talks given on a Workshop on Structure Based Drug Discovery June 4 (Athens, 2-6 June 2008, Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation). Titles of the talks: a. A concerted approach using NMR spectroscopy and Theoretical Calculations to study the Conformational Properties of a Potent Cannabinoid Analogue AMG-3. b. The Contribution of NMR Spectroscopy and other Biophysical Methodologies to study the Molecular Basis of Interdigitation. Natural Products, International Conference, Atheneum Intercontinental 3-8 August 2008, Athens, Greece.
182.Mavromoustakos, T., Petrou, C., Kokkalou, E., Roussis, V., Christofi, V., Efthimiou, G., Potamitis, C., Durdagi, S., Mavromoustakos, S. Ficus sycomorous sap: a psoralene source with potential for the treatment of psoriasis. 202. Koukoulitsa C., Tsantili-Kakoulidou A., T. Mavromoustakos, Chinou I. Natural coumarins and PLS analysis for antibacterial activity using VolSurf descriptors. Natural Products, International Conference, Atheneum Intercontinental 3-8 August 2008, Athens, Greece.
183.Mavromoustakos T., Durdagi, S., Papahadjis, D., Papadopoulos, M.G. X-ray diffraction studies combined with molecular dynamics calculations to study the effects of cannabinoids in lipid bilayers and CB receptor active site. Hellenic Crystallographic Association 4th conference decicated to the memory of Dr. N. Oikonomakos. 26-27 September 2008, Athens, Greece. Abstract book page 23.
184.(invited speaker) Mavromoustakos T., Durdagi, S., Reis, H., Koukoulitsa, C., Papadopoulos, M. A Concerted Approach Using Physical Chemical Methodologies, Computational Chemistry and 3D QSAR Studies Aiming to Develop Novel Analgesic Cannabinoid Analogs. P-124. Ehrlich II, 2nd World Conference on Magic Bullets. Celebrating the 100th Anniversary of the Nobel Prize Awarded to Paul Erhlich. Nurnberg, Germany October 3-5, 2008.
185.T. Mavromoustakos. Rational Drug Design. 3.11.2008, (honoured to Prof.) Dale Poulter.
186.T. Mavromoustakos. Novel Strategies in the Drug Design. Workshope 5-6 December 2008 held in NHRF, Athens.
187.C. Koukoulitsa, A.Tsantili-Koukoulidou, T. Mavromoustakos. Quantitative Structure Retention Relationships for IAM Chromatographic Indices using VolSurf Approach. Comparison with Octanol-Water Distribution Coefficients. logP2009. PhysChem and ADMET Profiling in Drug Research. The 4th LogP Symposium. February 8-11, 2009, ETH Zurich, Switzerland.
188.C. Koukoulitsa, T. Mavromoustakos, S. Durdagi, V. Mouchlis, A. Politi, P. Minakaki, M.G. Papadopoulos, G. Kokotos. Rational Design Applications in the Drug Discovery. 10th Conference with International Participation in Medicinal Chemistry, Drug Discovery and Design, March 18-20, Patras, Greece, 2009 (abstract proceedings page 73).
189.C. Potamitis, M. Zervou, T. Tselios, J. Matsoukas, K. Viras, T. Mavromoustakos. Study of Myelin Basic Protein Peptide analogues interactions with lipid bilayers using DSC, Raman and Solid State 13C and 31P NMR Spectroscopy. 10th Conference with International Participation in Medicinal Chemistry, Drug Discovery and Design, March 18-20, Patras, Greece, 2009 (abstract proceedings page 90).
190.M. Smyrniotakis, P. Zoumpoulakis, T. Mavromoustakos. Conformational Studies of AT1 Antagonists in Micelle and Liposomal Environment. 10th Conference with International Participation in Medicinal Chemistry, Drug Discovery and Design, March 18-20, Patras, Greece, 2009 (abstract proceedings page 93).
191.C. Fotakis, D. Christodouleas, M. Zervou, N.P. Benetis, K. Viras, T. Mavromoustakos. Development of a CP-31 NMR broadline simulation methodology for studying the interactions of antihypertensive AT1 antagonist losartan with phospholipid bilayers. 10th Conference with International Participation in Medicinal Chemistry, Drug Discovery and Design, March 18-20, Patras, Greece, 2009 (abstract proceedings page 101).
192.(invited speaker). T. Mavromoustakos. Interdigitation effects of drugs incorporated in lipid bilayers: Possible consequences in rational drug design. Theobio09. 4th International Symposium of Theoretical Biophysics. Roscoff June 29-July 3.
193.(speaker) T. Mavromoustakos. 3th Hellenic Symposium on Organic Synthesis.From Chemistry to Biology, Medicine and Materials Science. 15-17 October 2009. University of Athens. The biodiversity in nature provides solutions to synthetic organic chemists.
194.(poster) E. Papavassilopoulou, P. Moutevelis-Minakakis, D. Delivoria, T. Mavromoustakos, G. Kokotos. Synthesis of new 2-pyrrolidinones as potential rennin inhibitors. Hellenic Symposium on Organic Synthesis.From Chemistry to Biology, Medicine and Materials Science. 15-17 October 2009. University of Athens.
195.(poster) C. Potamitis, M. Matsoukas, T. Tselios, S.G. Grdadolnik, T. Mavromoustakos. Conformational Analysis of Myelin Basic Protein. Peptide Analogues with the use of NMR spectroscopy and molecular dynamic simulations. Hellenic Hellenic Symposium on Organic Synthesis.From Chemistry to Biology, Medicine and Materials Science. 15-17 October 2009. University of Athens.
196.(poster) N. Neophytou, C. Koukoulitsa, V. Mouchlis, E. Papavassilopoulou, K. Georgikopoulou, G. Michas, T. Mavromoustakos, P. Moutevelis-Minakakis, G. Kokotos, D. Hadjipavlou. Doking studies of pyrrolidinone derivatives to soybean lipoxygenase-3. Hellenic Symposium on Organic Synthesis.From Chemistry to Biology, Medicine and Materials Science. 15-17 October 2009. University of Athens.
197.(poster) V. Mouchlis, V. Magrioti, N. Cermak, A. Bilger, R. Oslund, T. Mavromoustakos, M. Gelb, G. Kokotos. Molecular Modeling studies of secreted phospholipase A2 inhibition by 2-oxoamides based on α-amino acids. Hellenic Symposium on Organic Synthesis.From Chemistry to Biology, Medicine and Materials Science. 15-17 October 2009. University of Athens.
198.(poster) V. Mouchlis, M. Kokotou, F. Sympoura, T. Mavromoustakos, V. Constantinou-Kokotou. Molecular Modeling studies of secreted phospholipase A2 inhibition by natural products. Hellenic Symposium on Organic Synthesis.From Chemistry to Biology, Medicine and Materials Science. 15-17 October 2009. University of Athens.
199.C. Potamitis, T. Tselios, J. Matsoukas, M. Matsoukas, T. Mavromoustakos. Interdigitation of peptide analogs in lipid bilayers. Dr C Potamitis was one of the 10 Ph.D. students selected to present the oral communication during the XXIX Advanced Course of European School of Medicinal Chemistry and “E. Duvanti”, National Seminar for PhD students, Urbino September 13-18, 2009.
200.P. Zoumpoulakis, S. Durdagi, C. Potamitis, E. Kritsi, S.G. Grdadolnik, T. Mavromoustakos. Comparative conformational analysis and docking studies between telmisartan and valsartan. Insights on the molecular basis of action of their pharmacophores associated with AT1 antagonism. 14th Hellenic Symposium on Medicinal Chemistry. 23-25 April, 2010. Thessaloniki, Greece.
201.V. Mouchlis, V. Michopoulou, T. Mavromoustakos, G. Kokotos. Molecular Docking and Molecular Dynamics simulations on 2-oxoamide cytosolic phospholipase A2 inhibitors. 14th Hellenic Symposium on Medicinal Chemistry. 23-25 April, 2010. Thessaloniki, Greece.
202.(poster) N. Neophytou, E. Papavassilopoulou, G. Michas, V. Mouchlis, C. Koukoulitsa, M. Zheng, D. Hadjipavlou-Litina, G. Kokotos, P. Moutevelis-Minakakis, T. Mavromoustakos. An attempt to rationally design inhibitors through docking experiments at the active site of lipoxygenase-3. 11th 14th Hellenic Symposium on Medicinal Chemistry. 23-25 April, 2010. Thessaloniki, Greece.
203.(poster) V. Michopoulou, V. Mouchlis, T. Mavromoustakos, G. Kokotos. Studies on the interactions of the active site of cytosolic phospholipase A2 with inhibitors containing activated carbonyl functionalities. 14th Hellenic Symposium on Medicinal Chemistry. 23-25 April, 2010. Thessaloniki, Greece.
204.(poster) M. Kokotou, V. Mouchlis, T. Mavromoustakos, V. Constantinou-Kokotou. Molecular Modeling studies of secreted phospholipase A2 inhibition by oleuropein. 14th Hellenic Symposium on Medicinal Chemistry. 23-25 April, 2010. Thessaloniki, Greece.
205.(invited speeker) T. Mavromoustakos. The molecules of the brain. A speech dedicated to composer and chemist M. Plessas. 11th Conference with International Participation on Medicinal Chemistry:Drug Discovery and Design. April 25-28, 2010, Patras, Greece.
206.(poster) E. Kritsi, S. Chatziaggeloglou, P. Zoumpoulakis, C. Potamitis, N. Papakonstantopoulos, T. Mavromoustakos. Comparative Conformational Analysis Study of Candesartan with Eprosartan and Losartan. 11th Conference with International Participation on Medicinal Chemistry:Drug Discovery and Design. April 25-28, 2010, Patras, Greece.
207.(poster) C. Koukoulitsa, M. Chrysanthakopoulos, D. Vrakas, C. Giaginis, T. Mavromoustakos, A. T. Kakoulidou. The use of volsurf approach to explore IAM and HAS chromatographic indices. 18th EuroQSAR 19-24 September 2010. Rhodes-Greece.
208.(poster) V. Michopoulou, V. Mouchlis, T. Mavromoustakos, G. Kokotos. Molecular Docking studies of inhibitors containing activated carbonyl functionalities in the active site of cytosolic phospholipase A2. 18th EuroQSAR 19-24 September 2010. Rhodes-Greece.
209.(poster) V. Mouchlis, T. Mavromoustakos, G. Kokotos. Molecular Docking and 3D-QSAR COMFA studies on indole inhibitors of GIIA secreted phospholipase A2. 18th EuroQSAR 19-24 September 2010. Rhodes-Greece.
210.(poster) N. Neophytou, G. Michaw, D. Hadjipavlou-Litina, M. Zheng, G. Kokotos, P. Moutevelis-Minakakis, T. Mavromoustakos. Comparative docking studies at the active site of lipoxygenase-3, lipoxygenase-5 and cyclooxygenase-2. 18th EuroQSAR 19-24 September 2010. Rhodes-Greece.
211.(invited speaker). T. Mavromoustakos. The Use of High Resolution Liquid and Solid State NMR Spectroscopy in the Rational Drug Design. EAST-NMR meeting. Satellite of 18th EuroQSAR 24-26 September 2010. Rhodes-Greece.
212.T. Mavromoustakos. Cerebrosides, myelin, hormone LHRH,brain. Review of Clinical Pharmacology and Pharmacokinetics. 25, 21,2011.
213.E. Kritsi, S. Chatziaggeloglou, P. Zoumpoulakis, C. Potamitis, N. Papakonstantopoulos, T. Mavromoustakos. Review of Clinical Pharmacology and Pharmacokinetics. 25, 31,2011.
214.(invited speaker) T. Mavromoustakos, S. Durdagi, C. Koukoulitsa, M.G. Papadopoulos, C. Tzoupis. Strategies in the Rational Drug Design. 25th National Chemistry Congress with International Participation. Erzurum Turkey, 27 June-2 July 2011.
215.S. Durdagi, H.J. Duff, S.Y. Noskov, T. Mavromoustakos, M.G. Papadopoulos, C.T. Supuran, M. Senturk, D. Ekinci. Applications of Computational Chemistry Approaches to Biological Systems: Recent Advances and Future Directions in Computer-Aided Drug Design Studies. 25th National Chemistry Congress with International Participation. Erzurum Turkey, 27 June-2 July 2011.
216.(invited speaker) T. Mavromoustakos. Strategies used to design new medicine. Austin, Texas, USA, August 4, 2011.
217.V. Mouchlis, V. Magrioti, E. Barbayianni, T. Mavromoustakos, M.H. Gelb, G. Kokotos. 29th Trends in Drug Research. Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, Cyprus, October 2-7, 2011.
218.K. Gkountelias, K. Spyridaki, P. Giannopoylos, A. Akritides, M. Papadokostaki, T. Mavromoustakos, G. Liapakis. Determination of Residues in the Third Membrane Spanning Segment of CRF1, which are accessible in the ligand binding-site crevice of receptor. Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, Cyprus, October 2-7, 2011.
219.E. Vrontaki, S.K. Hadjikakou, S. Golic Grdadolnik, T. Mavromoustakos. NMR spectroscopy and docking study of complex Ag(tpp)3(asp) to soybean lipoxygenase-1. Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, Cyprus, October 2-7, 2011.
220.C. Koukoulitsa, G. Agelis, A. Resvani, J. Matsoukas, T. Mavromoustakos. Structural elucidation conformational properties and molecular docking study at Bace-1 of bioactive molecule BV6. Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, Cyprus, October 2-7, 2011.
221.V. Nikoletta, M. Gregory, A. Tsotinis, M. Papadopoulos, T. Mavromoustakos. Docking, molecular dynamics and NMR spectroscopy study of two new cytotoxic c2-substituted pyrrolo [2,3-f] quinolines. Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, Cyprus, October 2-7, 2011.
222.D. Ntountaniotis, G. Mali, S.G. Grdadolnik, M. Halabalaki, A.L. Skaltsounis, C. Potamitis, E. Siapi, P. Hatzigeorgiou, M. Rappolt, T. Mavromoustakos. Thermal and dynamic properties of drug AT1 antagonist olmesartan in lipid bilayers using various physical-chemical methodologies. Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, Cyprus, October 2-7, 2011.
223.(invited) T. Mavromoustakos. Rational Drug Design. Structure-&Computer-aided Design Workshop:Bioactive Molecules&Materials. 7-11 November, 2011. Athens, Greece.
224.H. Tzoupis, G. Leonis, S. Durdagi, V. Mouchlis, T. Mavromoustakos, M.G. Papadopoulos. Binding of Novel Fullerene Inhibitors to HIV-1 Protease:Insight through Molecular Dynamics and Molecular Mechanics Poisson-Boltzmann Surface Area Calculations.Structure-&Computer-aided Design Workshop:Bioactive Molecules&Materials. 7-11 November, 2011. Athens, Greece.
225.(invited speaker) T. Mavromoustakos, C. Koukoulitsa, X. Tzoupis, M. Papadopoulos, G. Leonis, D. Ntountaniotis, G. Aggelis, T. Tselios, J. Matsoukas, G. Liapakis, E. Vrontaki, S.K. Hadjikakou, S. Golic Grdadolnik, M. Simcic, G. Mali, C. Glaubitz, J. Baldus, S. Durdagi. Applications of NMR Spectroscopy in the Organic and Medicinal Chemistry, EuAsC2S-12 April 16-21 2012, Corfu, Greece.
226. (poster) E. Vrontaki, A. Maniati, N. Varvarigou, G. Megariotis, G. Leonis, M. Vlachou, A. Eikosipentaki, R. Kompogennitaki, M. Papadopoulos, S.G. Grdadolnik, T. Mavromoustakos, A. Tsotinis. Conformational Analysis of two novel cytotoxic C2-substituted pyrrolo[2,3-f]quinolines in organic and aqueous media, membrane bilayers and at the putative active site. 30th Noordwijkerhout-Camerino-Cyprus-Symposium. May 13th- 17th , 2012, Royal Tropical Institute Amsterdam.
227.C. Koukoulitsa, C. Villalonga-Barber, B.R. Steele, O. Belda, M. Micha-Screttas, T. Mavromoustakos. Rational Design and Biological Evaluation of Novel Resveratrol and Glyoxylato-aroylhydrazone analogs against Alzheimer disease. 15th Hellenic Symposium on Medicinal Chemistry Athens, May 25-27, 2012.
228.T. Charalambos, G. Leonis, S. Durdagi, V. Mouchlis, T. Mavromoustakos, M. Papadopoulos. Binding of novel fullerene inhibitors to HIV-1 protease: Insight through molecular dynamics and molecular mechanics poisson-boltzmann surface area calculations. 15th Hellenic Symposium on Medicinal Chemistry Athens, May 25-27, 2012.
229.N. Stavrinoudakis, N. Neophytou, V. Magrioti, T. Mavromoustakos, G. Kokotos. Probing for novel and selective monoglyceride lipase inhibitors. 15th Hellenic Symposium on Medicinal Chemistry Athens, May 25-27, 2012.
230.A. Afantitis, G. Melagraki, C. Koukoulitsa, M. Koufaki, T. Mavromoustakos. Modelling and predicting oxidative stress-induced neuronal damage by chroman analogues. 15th Hellenic Symposium on Medicinal Chemistry Athens, May 25-27, 2012.
231.E. Vrontaki, M. Simcic, S. Golic-Grdadolnik, S.K. Hadjiikakou, T. Mavromoustakos. Study of the conformation of Cu complexes with aspirin. 15th Hellenic Symposium on Medicinal Chemistry Athens, May 25-27, 2012.
232.K. Spyridaki, K. Gkoutelias, T. Tselios, V. Magafa, R. Exarchakou, M. Papadokostaki, T. Mavromoustakos, G. Liapakis. Structure-function analysis of the second extracellular loop of type 1 receptor of the corticotrophin releasing factor, S90. Abstracts 32nd European Peptide Symposium, 2-7 September 2012, Athens, Greece. Journal of Peptide Science 18, S1, 1-224.
233.S. Vasilakaki, E. Barbayianni, T.M. Mavromoustakos, M.H. Gelb, G. Kokotos. Hydrophobic a-Amino Acids Favour the Inhibition of Human GIIA Phospholipase A2 by 2-Oxoamides, S95-S96. Abstracts 32nd European Peptide Symposium, 2-7 September 2012, Athens, Greece. Journal of Peptide Science 18, S1, 1-224.
234.A. Politi, G. Leonis, H. Tzoupis, D. Ntountaniotis, M.G. Papadopoulos, S.G. Gardadolnik, T. Mavromoustakos. Conformational properties and energetic analysis of aliskiren in solution and receptor site, S109. Abstracts 32nd European Peptide Symposium, 2-7 September 2012, Athens, Greece. Journal of Peptide Science 18, S1, 1-224.
235.G. Aggelis, A. Resvani, S. Durdagi, T. Tumova, J. Slaninov, P. Giannopoulos, K. Spyridaki, G. Liapakis, D. Vlahakos, T. Mavromoustakos, J. Matsoukas. A concise synthesis, docking studies and biological evaluation of N-substituted 5-butylimidazole analogues as potent angiotensin II receptor blockers, S116. Abstracts 32nd European Peptide Symposium, 2-7 September 2012, Athens, Greece. Journal of Peptide Science 18, S1, 1-224.
236.A. Resvani, C. Nikolis, G. Liapakis, D. Vlahakos, C. Koukoulitsa, D. Ntountaniotis, T. Mavromoustakos, J. Matsoukas, G. Agelis. Facile and Efficient Syntheses of Structurally Modified E-urocanic Acid Analogs as Potent Anagiotensin II Receptor Blockers, S120. Abstracts 32nd European Peptide Symposium, 2-7 September 2012, Athens, Greece. Journal of Peptide Science 18, S1, 1-224.
237.G. Agelis, A. Resvani, C. Koukoulitsa, A. Afantitis, G. Melegraki, A. Siafaka, E. Gkini, T. Tumova, K. Spyridaki, D. Kalavizioti, M-E Androutsou, J. Sianinova, G. Liapakis, D. Vlahakos, T. Mavromoustakos, J. Matsoukas. Rational Design, Efficient Synthesis, Biological Evaluation of New N,N '-bis-substituted Butylimidazole Analogs as Potent Angiotensin Receptor Blockers,, S123. Abstracts 32nd European Peptide Symposium, 2-7 September 2012, Athens, Greece. Journal of Peptide Science 18, S1, 1-224.
238.H. Tzoupis, G. Leonis, G. Megariotis, C.T. Supuran, T. Mavromoustakos, M.G. Papadopoulos. Effective inhibition of aspartic proteases: Advancements in aids-hypertension-diabetes linkage. International Conference on Chemistry for Health. Athens, 9-14 September 2012, Athens, Greece.
239.A. Politi, G. Leonis, H. Tzoupis, D. Ntountaniotis, M.G. Papadopoulos, S.G. Gardadolnik, T. Mavromoustakos. Conformational properties and energetic analysis of aliskiren in solution and receptor site. International Conference on Chemistry for Health. Athens, 9-14 September 2012, Athens, Greece.
240.(invited speech and poster) D. Ntountaniotis, P. Kolokotroni, J. Baldus, C. Glaubitz, T. Mavromoustakos. Exploring the molecular basis of interactions of candesartan cilexitil (TCV-116) in lipid bilayers suing solid state NMR spectroscopy. 3rd Annual East-NMR User Meeting. Lasko, Slovenia, November 13-16, 2012.

241.(invited speech) T. Mavromoustakos. “Successful and Unsuccessful stories in the Rational Drug Design”. BAU International Drug Design Symposium Istanbul, 21-23 March 2013.


242.(invited workshop) T. Mavromoustakos. Theoretical Background for the use of NMR Spectroscopy and Molecular Modeling to Predict of Putative Bioactive Conformation of Drugs”. BAU International Drug Design Symposium Istanbul, 21-23 March 2013.
243.(invited workshop) T. Mavromoustakos. A reaction in the NMR tube can be converted to a facile method of preparing methyl ethers. 2nd SEE-dRUG Workshop-NMR Basics&Applications in Life Sciences.
244.T. Mavromoustakos. A facile and efficient drug:active site interactions and a synthetic method for methyl ethers.NMR in protein dynamics and structural biology 10-13 June, 2013 Budapest.
245.G. Kordopati, T. Tselios, T. Mavromoustakos, S.G. Gardadolnik, G. Tsivgoulis. Synthesis and interaction studies of β-cyclodextrin/hrh analogue conjugate by using nmr spectroscopy. NMR in protein dynamics and structural biology 10-13 June, 2013 Budapest.

246. Maria Zervou,Zoe Cournia, Constantinos Potamitis,George Patargias, Serdar Durdagi, Simona Golic Grdadolnik,Thomas Mavromoustakos. The Molecular Basis of Action of the AT1 antagonist Losartan. Coupling between protein, water, and lipid dynamics in complex biological systems: Theory and Experiments Conference, September 24-27, 2013, CECAM-HQ-EPFL, Lausanne, Switzerland.

247. Ε.Koulouridi, V. Magrioti, G. Kokotos, T. Mavromoustakos, In Silico screening for new inhibitors of human cytosolicphospholipase cPLA2 and molecular docking experiments Review Clinical Pharmacology and Pharmacokinetics International Edition 27,79 (2013).
248. C. Koukoulitsa, C. Kontogiorgis, D. Hadjipavlou-Litina, T. Mavromoustakos In Silico studies of 3-aryl-coumarins as MAO-B receptor inhibitors Review Clinical Pharmacology and Pharmacokinetics International Edition 27,80 (2013).
249. G. Kordopati, T. Tselios, T. Mavromoustakos, S. Golic Grdadolnik, G. Tsivgoulis, Synthesis and 2D NMR studies of a -cyclodextrin/LHRH analogue conjugate. Review Clinical Pharmacology and Pharmacokinetics International Edition 27,81 (2013).

250.P. Kolokotroni, D. Ntountaniotis, J. Baldus, C. Glaubitz, T. Mavromoustakos, Exploring the molecular basis of interactions of Candesartan Cilexetil (TCV-116) in lipid bilayers using 1H and 13C CP/MAS solid state NMR spectroscopy. Review Clinical Pharmacology and Pharmacokinetics International Edition 27,83 (2013).


251.T. Kellici, V. Magrioti, G. Kokotos, T. Mavromoustakos, Identification of novel selective MAGL inhibitors using pharmacophore models and molecular docking. Review Clinical Pharmacology and Pharmacokinetics International Edition 27,85 (2013).
252. S. Vasilakaki, C. Koukoulitsa, E. Barbagianni, T. Mavromoustakos, G. Kokotos In silico studies of the inhibition properties of GK241 and its analogues against secretory phospholipase sPLA2 GIIA. Review Clinical Pharmacology and Pharmacokinetics International Edition 27,87 (2013).
253. (invited speaker) T. Mavromoustakos, Drug:Membrane Interactions, November 14, 2013. Novartis Institutes for Biomedical Research, Horsham, RH12 5AB.
254.(invited speaker) T. Mavromoustakos, Drug:Membrane Interactions and Drug Discovery. 2nd International Bau Drug Design Congress. Novel Methods and Emerging Targets in Drug Discovery&Patented Drug Development. Istanbul April 17-19, 2014.
255.T. Mavromoustakos, Honorium to Prof. A. Makriyannis. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014
256.G. Kordopati, T. Tselios, T. Kellici, F. Merzel, T. Mavromoustakos, S.G. Grdadolnik, G. Tsivgoulis. Conformational studies of LHRH analogue conjugated with cyclodextrin using 2D NMR and Molecular Modeling. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014
257. G. Kordopati, T. Tselios, T. Kellici, F. Merzel, T. Mavromoustakos, S.G. Grdadolnik, G. Tsivgoulis. Conformational studies of LHRH analogue conjugated with cyclodextrin using 2D NMR and Molecular Modeling. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014.
258. T. Kellici, D. Ntountaniotis, G. Leonis, M. Chatziathanasiadou, A. Tzakos, J. Baldus, C. Glaubitz, G. Valsami, E. Archontaki, K. Viras, M.G. Papadopoulos, T. Mavromoustakos. Interactions of silybin A with cyclodextrin derivatives using solid and liquid state NMR spectroscopy, differential scanning and isothermal titration calorimetry as well as molecular dynamics simulations. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014.
259. E. Vrontaki, G. Melagraki, T. Mavromoustakos, A. Afantitis. An in silico effort to discover new HCV Replication Inhibitors. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014.
260. E. Vrontaki, G. Leonis, A. Avramopoulos, M.G. Papadopoulos, M. Simcic, S.Golic Grdadolnik, A. Afantitis, G. Melagraki, S.K. Hadjikakou, T. Mavromoustakos. Stability and Binding Effects of Ag Metal Complexes at LOX-1. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014.
261. S. Vasilakaki, G. Leonis, M.G. Papadopoulos, T. Mavromoustakos, G. Kokotos, Molecular Dynamics Simulations and MM-PBSA Binding Free Energy Estimation in GK241-sPLA2 GIIA complex. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014.
262. A.S. Foscolos, I. Papanastasiou, G. Foscolos, A. Tsotinis, T. Kellici, T. Mavromoustakos. Hydrazones of 5-nitro-2furanecarboxaldehyde with 1-adamantanealkanoyhydrazides with probable trypanocidal activity. 32nd Cyprus-Noordwijkerhout-Camerino Symposium. Limassol, 18-22 May 2014.
263. (poster presentation) S. Vasilakaki, T. Mavromoustakos, G. Kokotos. Review Clinical Pharmacology and Pharmacokinetics International Edition p. 28 devoted to the 15th Conference with International Participition held in Patras, April 9-11, 2014.
264. (poster presentation) S. Vasilakaki, T.Mavromoustakos, G. Kokotos. Docking studies on coumarin and quinolinone derivatives against sPLA2GIIA. Clinical Pharmacology and Pharmacokinetics International Edition p. 28 devoted to the 15th Conference with International Participition held in Patras, April 9-11, 2014, p. 44.
265. (poster presentation) T. Kellici, D. Ntountaniotis, G. Leonis, M. Chatziathanasiadou, A. Tzakos, J. Baldus, C. Glaubitz, G. Valsami, E. Archontaki, K. Viras, M.G. Papadopoulos, T. Mavromoustakos. Clinical Pharmacology and Pharmacokinetics International Edition p. 28 devoted to the 15th Conference with International Participition held in Patras, April 9-11, 2014, p. 45.
266. E. Vrontaki, G. Melagraki, T. Mavromoustakos, A. Afantitis. Exploiting CheMBL Database to identify indole analogues as HCV replication inhibitors. Clinical Pharmacology and Pharmacokinetics International Edition p. 28 devoted to the 15th Conference with International Participition held in Patras, April 9-11, 2014, p. 31.


ARTICLES OF GENERAL INTEREST


Author of 10 various articles in Greek language, related to education as well as of general interest (i.e. thermodynamics and entropy, the use of analogs in quantum chemistry, olive oil health and tradition etc).


  • ARTICLES RELATED TO THEOLOGY AND CIVILISATION Author of 25 articles in theology and civilisation published in Greek and Cypriot journals.




Yüklə 419 Kb.

Dostları ilə paylaş:
1   2   3   4   5




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©www.genderi.org 2024
rəhbərliyinə müraciət

    Ana səhifə